首页> 美国卫生研究院文献>Oncology Letters >MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction gene expression omnibus and bioinformatics study
【2h】

MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction gene expression omnibus and bioinformatics study

机译:MicroRNA-124-3p在肝细胞癌中的表达及其预期功能途径:定量聚合酶链反应基因表达综合和生物信息学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study aimed to explore the potential clinical significance of microRNA (miR)-124-3p expression in the hepatocarcinogenesis and development of hepatocellular carcinoma (HCC), as well as the potential target genes of functional HCC pathways. Reverse transcription-quantitative polymerase chain reaction was performed to evaluate the expression of miR-124-3p in 101 HCC and adjacent non-cancerous tissue samples. Additionally, the association between miR-124-3p expression and clinical parameters was also analyzed. Differentially expressed genes identified following miR-124-3p transfection, the prospective target genes predicted in silico and the key genes of HCC obtained from Natural Language Processing (NLP) were integrated to obtain potential target genes of miR-124-3p in HCC. Relevant signaling pathways were assessed with protein-protein interaction (PPI) networks, Gene Ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) and Protein Annotation Through Evolutionary Relationships (PANTHER) pathway enrichment analysis. miR-124-3p expression was significantly reduced in HCC tissues compared with expression in adjacent non-cancerous liver tissues. In HCC, miR-124-3p was demonstrated to be associated with clinical stage. The mean survival time of the low miR-124-3p expression group was reduced compared with that of the high expression group. A total of 132 genes overlapped from differentially expressed genes, miR-124-3p predicted target genes and NLP identified genes. PPI network construction revealed a total of 109 nodes and 386 edges, and 20 key genes were identified. The major enriched terms of three GO categories included regulation of cell proliferation, positive regulation of cellular biosynthetic processes, cell leading edge, cytosol and cell projection, protein kinase activity, transcription activator activity and enzyme binding. KEGG analysis revealed pancreatic cancer, prostate cancer and non-small cell lung cancer as the top three terms. Angiogenesis, the endothelial growth factor receptor signaling pathway and the fibroblast growth factor signaling pathway were identified as the most significant terms in the PANTHER pathway analysis. The present study confirmed that miR-124-3p acts as a tumor suppressor in HCC. miR-124-3p may target multiple genes, exerting its effect spatiotemporally, or in combination with a diverse range of processes in HCC. Functional characterization of miR-124-3p targets will offer novel insight into the molecular changes that occur in HCC progression.
机译:本研究旨在探讨microRNA(miR)-124-3p表达在肝癌发生和肝细胞癌(HCC)发展中的潜在临床意义,以及功能性HCC途径的潜在靶基因。进行了逆转录-定量聚合酶链反应以评估miR-124-3p在101肝癌及邻近非癌组织样品中的表达。此外,还分析了miR-124-3p表达与临床参数之间的关联。将miR-124-3p转染后鉴定的差异表达基因,计算机预测的预期靶基因和从自然语言处理(NLP)获得的HCC关键基因整合在一起,以获得HCC中miR-124-3p的潜在靶基因。通过蛋白质-蛋白质相互作用(PPI)网络,基因本体论(GO)富集分析,《京都基因与基因组百科全书》(KEGG)和“通过进化关系的蛋白质注释”(PANTHER)途径富集来评估相关的信号通路。与邻近的非癌性肝组织中的表达相比,HCC组织中的miR-124-3p表达显着降低。在肝癌中,miR-124-3p被证明与临床阶段有关。与高表达组相比,低miR-124-3p表达组的平均生存时间缩短了。共有132个基因与差异表达基因,miR-124-3p预测的靶基因和NLP鉴定的基因重叠。 PPI网络的构建揭示了总共109个节点和386个边缘,并鉴定了20个关键基因。三个GO类别的主要丰富术语包括细胞增殖的调控,细胞生物合成过程的正调控,细胞前沿,胞质和细胞投射,蛋白激酶活性,转录激活剂活性和酶结合。 KEGG分析显示,胰腺癌,前列腺癌和非小细胞肺癌是前三名。在PANTHER途径分析中,血管生成,内皮生长因子受体信号传导途径和成纤维细胞生长因子信号传导途径被确定为最重要的术语。本研究证实,miR-124-3p在HCC中起着抑癌作用。 miR-124-3p可能靶向多个基因,时空发挥其作用,或与HCC中各种过程结合使用。 miR-124-3p靶标的功能表征将为HCC进展中发生的分子变化提供新颖的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号